Products
We build a small number of products carefully, then run them for the long term. Our first product is GlucIQ; more subscription software for consumers, health, and business customers follows from the same playbook.
GlucIQ
GlucIQ is a diabetes-management mobile app for people with type 1 diabetes. It helps them track glucose, manage insulin, and understand food and nutrition in one record.
- Who it is for: people with type 1 diabetes who want clearer daily context on glucose, insulin, and meals.
- Status: in development for the Apple App Store and Google Play.
- The product site: detailed feature work and background live on gluciq.com.
GlucIQ
gluciq.com
GlucIQ is being designed and tested for safety and usability before any public launch. No release date is promised until the app meets our own bar for quality.
Visit gluciq.comA deliberate path to more products
One product at a time, each funded by its own users. This is where we are honest about what comes next, without overpromising.
Subscription consumer apps
Ongoing development and operation of a portfolio of subscription-based consumer and health-technology apps, built on the lessons of GlucIQ.
B2B SaaS products
Software licensed to business customers, with the same focus on reliability, clear pricing, and support that we bring to consumer products.
Long-term operation
Each product is a commitment, not a launch event. We staff for the boring work of updates, security, and support that keeps software trustworthy.
What we will not do
We will not announce products that do not exist yet, publish metrics we cannot stand behind, or claim launches that have not happened.
What we will do
Announce each product when it is real, describe it accurately, and update these pages as the portfolio grows.
Want to know more about GlucIQ?
The product site has the detail. For questions about AviyanLabs itself, email us.